209 related articles for article (PubMed ID: 24874845)
41. Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes.
McMillan M; Porritt K; Kralik D; Costi L; Marshall H
Vaccine; 2015 Apr; 33(18):2108-17. PubMed ID: 25758932
[TBL] [Abstract][Full Text] [Related]
42. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
Yates L; Pierce M; Stephens S; Mill AC; Spark P; Kurinczuk JJ; Valappil M; Brocklehurst P; Thomas SH; Knight M
Health Technol Assess; 2010 Jul; 14(34):109-82. PubMed ID: 20630123
[TBL] [Abstract][Full Text] [Related]
43. Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling design.
Ludvigsson JF; Ström P; Lundholm C; Cnattingius S; Ekbom A; Örtqvist Å; Feltelius N; Granath F; Stephansson O
BMJ; 2015 Nov; 351():h5585. PubMed ID: 26572546
[TBL] [Abstract][Full Text] [Related]
44. Risk of adverse maternal and foetal outcomes associated with inactivated influenza vaccination in first trimester of pregnancy.
Speake HA; Pereira G; Regan AK
Paediatr Perinat Epidemiol; 2021 Mar; 35(2):196-205. PubMed ID: 33155331
[TBL] [Abstract][Full Text] [Related]
45. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803
[TBL] [Abstract][Full Text] [Related]
46. Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.
Chambers CD; Johnson DL; Xu R; Luo YJ; Louik C; Mitchell AA; Schatz M; Jones KL;
Vaccine; 2016 Aug; 34(37):4443-9. PubMed ID: 27449682
[TBL] [Abstract][Full Text] [Related]
47. A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination.
Reisinger KS; Holmes SJ; Pedotti P; Arora AK; Lattanzi M
Hum Vaccin Immunother; 2014; 10(8):2395-407. PubMed ID: 25424947
[TBL] [Abstract][Full Text] [Related]
48. Medical Outcomes in Women Who Became Pregnant after Vaccination with a Virus-Like Particle Experimental Vaccine against Influenza A (H1N1) 2009 Virus Tested during 2009 Pandemic Outbreak.
Cérbulo-Vázquez A; Arriaga-Pizano L; Cruz-Cureño G; Boscó-Gárate I; Ferat-Osorio E; Pastelin-Palacios R; Figueroa-Damian R; Castro-Eguiluz D; Mancilla-Ramirez J; Isibasi A; López-Macías C
Viruses; 2019 Sep; 11(9):. PubMed ID: 31533277
[TBL] [Abstract][Full Text] [Related]
49. Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months.
Esposito S; Pugni L; Daleno C; Ronchi A; Valzano A; Serra D; Mosca F; Principi N
Pediatrics; 2011 May; 127(5):e1161-8. PubMed ID: 21464195
[TBL] [Abstract][Full Text] [Related]
50. Maternal influenza vaccine and risks for preterm or small for gestational age birth.
Nordin JD; Kharbanda EO; Vazquez Benitez G; Lipkind H; Vellozzi C; Destefano F;
J Pediatr; 2014 May; 164(5):1051-1057.e2. PubMed ID: 24582484
[TBL] [Abstract][Full Text] [Related]
51. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study.
Launay O; Krivine A; Charlier C; Truster V; Tsatsaris V; Lepercq J; Ville Y; Avenell C; Andrieu T; Rozenberg F; Artiguebielle F; Tréluyer JM; Goffinet F;
PLoS One; 2012; 7(12):e52303. PubMed ID: 23300637
[TBL] [Abstract][Full Text] [Related]
52. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
[TBL] [Abstract][Full Text] [Related]
53. The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.
McHugh L; Marshall HS; Perrett KP; Nolan T; Wood N; Lambert SB; Richmond P; Ware RS; Binks P; Binks MJ; Andrews RM
Clin Infect Dis; 2019 Jan; 68(3):402-408. PubMed ID: 30475988
[TBL] [Abstract][Full Text] [Related]
54. Effect of influenza vaccination in the first trimester of pregnancy.
Sheffield JS; Greer LG; Rogers VL; Roberts SW; Lytle H; McIntire DD; Wendel GD
Obstet Gynecol; 2012 Sep; 120(3):532-7. PubMed ID: 22914461
[TBL] [Abstract][Full Text] [Related]
55. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study.
Omon E; Damase-Michel C; Hurault-Delarue C; Lacroix I; Montastruc JL; Oustric S; Escourrou B
Vaccine; 2011 Dec; 29(52):9649-54. PubMed ID: 22036887
[TBL] [Abstract][Full Text] [Related]
56. Seasonal and pandemic influenza during pregnancy and risk of fetal death: A Norwegian registry-based cohort study.
Gunnes N; Gjessing HK; Bakken IJ; Ghaderi S; Gran JM; Hungnes O; Magnus P; Samuelsen SO; Skrondal A; Stoltenberg C; Trogstad L; Wilcox AJ; Håberg SE
Eur J Epidemiol; 2020 Apr; 35(4):371-379. PubMed ID: 31950373
[TBL] [Abstract][Full Text] [Related]
57. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks?
Kwong W; Tomlinson G; Feig DS
Am J Obstet Gynecol; 2018 Jun; 218(6):573-580. PubMed ID: 29454871
[TBL] [Abstract][Full Text] [Related]
58. Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews.
Juvet LK; Robertson AH; Laake I; Mjaaland S; Trogstad L
Front Immunol; 2021; 12():740048. PubMed ID: 34777351
[TBL] [Abstract][Full Text] [Related]
59. H1N1 influenza vaccination during pregnancy.
Fell DB; Dodds L; McNeil S; MacDonald NE
BMJ; 2014 May; 348():g3500. PubMed ID: 24874846
[No Abstract] [Full Text] [Related]
60. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
Granath F; Gedeborg R; Smedje H; Feltelius N
Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
